Cancer Exosomal miRNA as Biomarkers for Early Diagnosis and Prognosis of Colorectal CancerCarine RizkJune 28, 2022 4:24 pmS2-Hydroxyglutarate Utilization as a Target for Therapy in the IDH Mutant Pediatric High-Grade GliomaJacob ParisJune 28, 2022 12:26 pmThe Future of Osteosarcoma Treatment: 3D PrintingHunter MansfieldJune 28, 2022 12:19 pmThe Role of CXCR2 and its Associated Ligands in the Progression and Management of Colorectal CancerMichael GengJune 27, 2022 11:00 amDownregulation of IL-1B Pathway in Tumor Microenvironment Demonstrates Therapeutic Potential in Slowing Proliferation and Development of Breast Cancer Bone MetastasesPujita MunnangiJune 27, 2022 10:45 amFGFR1 Inhibitors Increase Susceptibility of EMT/EGFR Mutated Cells to TKIs in Non-small Cell Lung CancerAaron VengalilJune 26, 2022 4:26 pmSynthetic Lethality Implications for BRCA Mutation Cancers and BeyondHannah BassJune 24, 2022 4:10 pmTargeting Hypoxia Induced Activation of HIF-1a in Drug Resistant MelanomaNeha AroraJune 24, 2022 10:11 amOptimizing High-Testosterone Treatment of Castration Resistant Prostate Cancer through the Tumor Suppressor Capabilities of Androgen ReceptorSantiago QuevedoJune 23, 2022 6:01 pmNovel Immunotherapies such as CD22-targeted CAR T Cells and Anti-CD19 scFv hCAR T Cells May Offer Solutions for Relapsed/Refractory B cell Acute Lymphoblastic LeukemiaJeffery WhiteJune 23, 2022 5:55 pm